Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for IMIGLUCERASE
- An Efficacy and Safety Study of AVR-RD-02 Compared to Enzyme Replacement Therapy for Treatment of Gaucher Disease Type 3
- Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3
- A Phase I Study to Compare Abcertin and EU-sourced Cerezyme® in Healthy Volunteers
- Study to Evaluate Efficacy and Safety of Imiglucerase Treatment in Chinese Patients With Gaucher Disease Type Ⅲ
- Assessing the Impact of Elelyso on Bone Involvement Currently Treated With Other ERTs
- Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3
- Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3
- Phase III Study of ISU302 in Patients With Type 1 Gaucher Disease
- Intra-monocyte Imiglucerase Kinetics in Gaucher Disease
- A Multicenter Extension Study of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease
- The Safety and Efficacy Study of ISU302 in Patient With Type I Gaucher Disease
- Validating a New Severity Score System for Adults With Type 1 Gaucher Disease (GD1)
- Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease
- Treatment Protocol of Velaglucerase Alfa for Patients With Type 1 Gaucher Disease
- A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE)
- A Study in Type 1 Gaucher Patients to Evaluate the Pharmacokinetics, Safety and Pharmacodynamics of AT2101
- Switchover Trial From Imiglucerase to Plant Cell Expressed Recombinant Human Glucocerebrosidase
Clinical trials list
click for details